These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells. Ravel S, Casellas P. Eur J Biochem; 1990 Sep 11; 192(2):469-73. PubMed ID: 2209602 [Abstract] [Full Text] [Related]
3. Cyclosporin A and cyclosporin SDZ PSC 833 enhance anti-CD5 ricin A-chain immunotoxins in human leukemic T cells. Jaffrézou JP, Sikic BI, Laurent G. Blood; 1994 Jan 15; 83(2):482-9. PubMed ID: 7506953 [Abstract] [Full Text] [Related]
4. Antigenic modulation by anti-CD5 immunotoxins. Manske JM, Buchsbaum DJ, Azemove SM, Hanna DE, Vallera DA. J Immunol; 1986 Jun 15; 136(12):4721-8. PubMed ID: 3086441 [Abstract] [Full Text] [Related]
5. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins. Manske JM, Buchsbaum DJ, Vallera DA. J Immunol; 1989 Mar 01; 142(5):1755-66. PubMed ID: 2465347 [Abstract] [Full Text] [Related]
10. Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin. Carrière D, Casellas P, Richer G, Gros P, Jansen FK. Exp Cell Res; 1985 Feb 01; 156(2):327-40. PubMed ID: 2857124 [Abstract] [Full Text] [Related]
11. In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain. Rostaing-Capaillon O, Casellas P. Cancer Immunol Immunother; 1991 Feb 01; 34(1):24-30. PubMed ID: 1722138 [Abstract] [Full Text] [Related]
12. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells. Jaffrézou JP, Levade T, Kuhlein E, Thurneyssen O, Chiron M, Grandjean H, Carrière D, Laurent G. Cancer Res; 1990 Sep 01; 50(17):5558-66. PubMed ID: 2386962 [Abstract] [Full Text] [Related]
13. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates. Leonard JE, Wang QC, Kaplan NO, Royston I. Cancer Res; 1985 Nov 01; 45(11 Pt 1):5263-9. PubMed ID: 3876881 [Abstract] [Full Text] [Related]
14. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S, Villa S, Bregni M, Bonnadonna G, Gianni AM. Blood; 1987 Jan 01; 69(1):345-8. PubMed ID: 3098324 [Abstract] [Full Text] [Related]
15. Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates. Chiron M, Derocq JM, Kuhlein E, Roubinet F, Demur C, Grandjean H, Huguet F, Jaffrezou JP, Jansen F, Laurent G. Leuk Res; 1989 Jan 01; 13(6):491-9. PubMed ID: 2788783 [Abstract] [Full Text] [Related]
16. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM. Transplantation; 1987 Mar 01; 43(3):421-6. PubMed ID: 3103275 [Abstract] [Full Text] [Related]
17. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia. Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA. J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241 [Abstract] [Full Text] [Related]
18. Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model. Chignola R, Pasti M, Candiani C, Franceschi A, Anselmi C, Tridente G, Colombatti M. Int J Cancer; 1995 May 16; 61(4):535-41. PubMed ID: 7538979 [Abstract] [Full Text] [Related]
19. Antigenic modulation induced by four monoclonal antibodies adsorbed on gold particles (specificity anti-CD4, anti-CD5, anti-CD7, and anti-150-kDa antigen): relationship between modulation and cytotoxic activity of immunotoxins. Carriere D, Arcier JM, Derocq JM, Fontaine C, Richer G. Exp Cell Res; 1989 May 16; 182(1):114-28. PubMed ID: 2785456 [Abstract] [Full Text] [Related]
20. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. Byers VS, Pawluczyk IZ, Hooi DS, Price MR, Carroll S, Embleton MJ, Garnett MC, Berry N, Robins RA, Baldwin RW. Cancer Res; 1991 Apr 15; 51(8):1990-5. PubMed ID: 2009518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]